Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001226
Filing Date
2025-05-13
Accepted
2025-05-13 16:04:18
Documents
72
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qnrx-20250331x10q.htm   iXBRL 10-Q 791953
2 EX-31.1 qnrx-20250331xex31d1.htm EX-31.1 14259
3 EX-31.2 qnrx-20250331xex31d2.htm EX-31.2 15014
4 EX-32.1 qnrx-20250331xex32d1.htm EX-32.1 6626
5 EX-32.2 qnrx-20250331xex32d2.htm EX-32.2 5845
  Complete submission text file 0001410578-25-001226.txt   4456081

Data Files

Seq Description Document Type Size
6 EX-101.SCH qnrx-20250331.xsd EX-101.SCH 42940
7 EX-101.CAL qnrx-20250331_cal.xml EX-101.CAL 31626
8 EX-101.DEF qnrx-20250331_def.xml EX-101.DEF 165582
9 EX-101.LAB qnrx-20250331_lab.xml EX-101.LAB 336333
10 EX-101.PRE qnrx-20250331_pre.xml EX-101.PRE 260284
75 EXTRACTED XBRL INSTANCE DOCUMENT qnrx-20250331x10q_htm.xml XML 559869
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 10-Q | Act: 34 | File No.: 001-37846 | Film No.: 25939903
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)